Page
1 of 3 >>
Global pharmaceutical
market growth accelerates to 11% in 1999
IMS HEALTH data shows that the world pharmaceutical market
grew by 10.7% in 1999, with estimated sales reaching $337.2
billion, up from $304.7 billion in 1998.
This robust growth is expected to continue, despite continued
government pressure on pricing and a number of blockbuster
drugs going off-patent. IMS HEALTH projections show average
annual global sales growth of 8.1% over the next five
years, which would expand the global pharmaceutical market
to $506 billion by 2004.
The growth can be attributed to a number of factors, including
the recent launches of drugs such as Celebrex
and Vioxx, which are contributing to the industry
momentum. Simultaneous multi-country launches, improved
sales force productivity and direct-to-consumer promotion
will continue to yield strong and faster sales in the
lifecycle of new drugs.
The data are a snapshot of IMS HEALTH's annual World
Review report of global pharmaceutical market performance
in 1999, using audited sales of prescription drugs and
certain over-the-counter products in more than 60 countries.
Growth in sales is measured in US dollars. World Review
is consolidated using IMS HEALTH's on-line global database,
MIDAS.
Leading countries
The top ten worldwide markets represent approximately
79% of all unaudited and audited sales.
|
Leading
countries in 1999 global pharmaceutical sales
|
|
Rank
|
Country
|
1999
Sales US$Bn
|
%
Global Sales
|
%
Growth Year-on-Year*
|
| 1
|
United
States |
130.1
|
39%
|
17%
|
| 2 |
Japan |
53.5 |
16%
|
23%
|
| 3
|
Germany
|
18.5
|
5%
|
1%
|
| 4
|
France
|
17.8
|
5%
|
0%
|
| 5
|
Italy
|
11.3
|
3%
|
3%
|
| 6
|
United
Kingdom |
11.0
|
3% |
8% |
| 7
|
Spain |
6.6 |
2%
|
6%
|
| 8
|
Brazil
|
6.3
|
2%
|
(-26%) |
|
9 |
China
|
6.2
|
2%
|
12%
|
| 10
|
Canada
|
5.5
|
2%
|
11% |
Source:
IMS HEALTH World
Review 2000 (*Growth measured in US Dollars)
The
US remains the largest pharmaceutical market by far, growing
17% to $130.1 billion in sales in 1999, and representing
39% of the total worldwide market. Japan, the second largest
market, recovered last year from three consecutive years
of negative performance, growing 23% with sales of $53.5
billion.
Within the top five European markets, Germany remains
in the lead, achieving sales of $18.5 billion with 1%
growth over 1998. The fastest growing Western European
markets in 1999 were the UK, growing 8%, and Spain, with
6% growth over 1998.
Brazil, the seventh largest audited world pharmaceutical
market in 1998, dropped to eighth place last year, experiencing
a 26% decline in growth due to economic conditions. China,
ranked ninth for the third consecutive year, achieved
$6.2 billion in 1999 sales and 12% year-over-year growth.
Detailed reports of sales for the Top 20 Corporations,
Products,
Countries
and Therapy
Areas in 1998 and 1999 are available to buy online.
See also: The global
pharmaceutical market report for 1998
|